{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T03:27:43Z","timestamp":1783826863623,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04264-3","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T12:17:08Z","timestamp":1750681028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chronic heart failure and hypoalbuminemia are risk factors of poorer mRNA SARS-CoV-2 vaccine response in maintenance Hemodialysis patients (the COVaccinDia study)"],"prefix":"10.1186","volume":"26","author":[{"given":"Pierre","family":"Laurent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Renou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najeh El","family":"Esper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Choukroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Pommerolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Laburthe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Caillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"issue":"7","key":"4264_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/toxins12070439","volume":"12","author":"G Cohen","year":"2020","unstructured":"Cohen G. Immune dysfunction in uremia 2020. Toxins 5 Juill. 2020;12(7):439.","journal-title":"Toxins 5 Juill"},{"issue":"5","key":"4264_CR2","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2215\/CJN.00950208","volume":"3","author":"S Kato","year":"2008","unstructured":"Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, et al. Aspects of immune dysfunction in End-stage renal disease. CJASN Sept. 2008;3(5):1526\u201333.","journal-title":"CJASN Sept"},{"issue":"1","key":"4264_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1053\/j.jrn.2011.10.020","volume":"22","author":"ND Vaziri","year":"2012","unstructured":"Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr Janv. 2012;22(1):149\u201356.","journal-title":"J Ren Nutr Janv"},{"issue":"3","key":"4264_CR4","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1172\/JCI83470","volume":"126","author":"J Rossaint","year":"2016","unstructured":"Rossaint J, Oehmichen J, Van Aken H, Reuter S, Pavenst\u00e4dt HJ, Meersch M, et al. FGF23 signaling impairs neutrophil recruitment and host defense during CKD. J Clin Invest 1 Mars. 2016;126(3):962\u201374.","journal-title":"J Clin Invest 1 Mars"},{"issue":"3","key":"4264_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4110\/in.2017.17.3.152","volume":"17","author":"JU Kim","year":"2017","unstructured":"Kim JU, Kim M, Kim S, Nguyen TT, Kim E, Lee S, et al. Dendritic cell dysfunction in patients with End-stage renal disease. Immune Netw. 2017;17(3):152.","journal-title":"Immune Netw"},{"issue":"4","key":"4264_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000330673","volume":"34","author":"HE Wang","year":"2011","unstructured":"Wang HE, Gamboa C, Warnock DG, Muntner P. Chronic kidney disease and risk of death from infection. Am J Nephrol. 2011;34(4):330\u20136.","journal-title":"Am J Nephrol"},{"issue":"8","key":"4264_CR7","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jiph.2020.01.314","volume":"13","author":"A Rteil","year":"2020","unstructured":"Rteil A, Kazma JM, El Sawda J, Gharamti A, Koubar SH, Kanafani ZA. Clinical characteristics, risk factors and microbiology of infections in patients receiving chronic Hemodialysis. J Infect Public Health Ao\u00fbt. 2020;13(8):1166\u201371.","journal-title":"J Infect Public Health Ao\u00fbt"},{"issue":"3","key":"4264_CR8","doi-asserted-by":"publisher","first-page":"100775","DOI":"10.1016\/j.xkme.2023.100775","volume":"6","author":"R Sam","year":"2024","unstructured":"Sam R, Rankin L, Ulasi I, Frantzen L, Nitsch D, Henner D, et al. Vaccination for patients receiving Dialysis. Kidney Med Mars. 2024;6(3):100775.","journal-title":"Kidney Med Mars"},{"issue":"6","key":"4264_CR9","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s11255-020-02451-9","volume":"52","author":"BM Henry","year":"2020","unstructured":"Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol Juin. 2020;52(6):1193\u20134.","journal-title":"Int Urol Nephrol Juin"},{"issue":"1","key":"4264_CR10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12882-020-02112-0","volume":"21","author":"S Kant","year":"2020","unstructured":"Kant S, Menez SP, Hanouneh M, Fine DM, Crews DC, Brennan DC, et al. The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation. BMC Nephrol D\u00e9c. 2020;21(1):449.","journal-title":"BMC Nephrol D\u00e9c"},{"issue":"3","key":"4264_CR11","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/jmv.26424","volume":"93","author":"J Li","year":"2021","unstructured":"Li J, Huang DQ, Zou B, Yang H, Hui WZ, Rui F, et al. Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol Mars. 2021;93(3):1449\u201358.","journal-title":"J Med Virol Mars"},{"issue":"2","key":"4264_CR12","doi-asserted-by":"publisher","first-page":"e3377","DOI":"10.1002\/dmrr.3377","volume":"37","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev F\u00e9vr. 2021;37(2):e3377.","journal-title":"Diabetes Metab Res Rev F\u00e9vr"},{"issue":"6","key":"4264_CR13","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.kint.2020.07.042","volume":"98","author":"C Couchoud","year":"2020","unstructured":"Couchoud C, Bayer F, Ayav C, B\u00e9chade C, Brunet P, Chantrel F, et al. Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French National cohort of dialysis patients. Kidney Int D\u00e9c. 2020;98(6):1519\u201329.","journal-title":"Kidney Int D\u00e9c"},{"key":"4264_CR14","doi-asserted-by":"crossref","unstructured":"Ichii M, Kurajoh M, Okute Y, Ihara Y, Imai T, Morioka T, et al. Reduced risk of progression from Non-Severe to severe COVID-19 in hospitalized Dialysis patients by full COVID-19 vaccination. J Clin Med. 2022;11(21):6348.","DOI":"10.3390\/jcm11216348"},{"issue":"2","key":"4264_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/hdi.13072","volume":"27","author":"DM Blankenship","year":"2023","unstructured":"Blankenship DM, Usvyat L, Lasky R, Maddux FW. COVID -19 vaccination status impact on mortality in end\u2010stage kidney disease. Hemodial Int Avr. 2023;27(2):197\u20139.","journal-title":"Hemodial Int Avr"},{"key":"4264_CR16","doi-asserted-by":"crossref","unstructured":"Kanai D, Wakui H, Hanaoka M, Haze T, Azushima K, Shinoda S et al. Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis. Clin Exp Nephrol. 28 mars. 2023;1\u20139.","DOI":"10.1007\/s10157-023-02342-0"},{"issue":"3","key":"4264_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10157-021-02156-y","volume":"26","author":"M Matsunami","year":"2022","unstructured":"Matsunami M, Suzuki T, Terao T, Kuji H, Matsue K. Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study. Clin Exp Nephrol Mars. 2022;26(3):305\u20137.","journal-title":"Clin Exp Nephrol Mars"},{"issue":"7","key":"4264_CR18","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2215\/CJN.03700321","volume":"16","author":"C Speer","year":"2021","unstructured":"Speer C, G\u00f6th D, Benning L, Buylaert M, Schaier M, Grenz J, et al. Early humoral responses of Hemodialysis patients after COVID-19 vaccination with BNT162b2. Clin J Am Soc Nephrol Juill. 2021;16(7):1073\u201382.","journal-title":"Clin J Am Soc Nephrol Juill"},{"issue":"11","key":"4264_CR19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41581-022-00617-5","volume":"18","author":"N Babel","year":"2022","unstructured":"Babel N, Hugo C, Westhoff TH. Vaccination in patients with kidney failure: lessons from COVID-19. Nat Rev Nephrol Nov. 2022;18(11):708\u201323.","journal-title":"Nat Rev Nephrol Nov"},{"issue":"9","key":"4264_CR20","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1681\/ASN.2021040490","volume":"32","author":"C Danthu","year":"2021","unstructured":"Danthu C, Hantz S, Dahlem A, Duval M, Ba B, Guibbert M, et al. Humoral response after SARS-CoV-2 mRNA vaccination in a cohort of Hemodialysis patients and kidney transplant recipients. J Am Soc Nephrol Sept. 2021;32(9):2153\u20138.","journal-title":"J Am Soc Nephrol Sept"},{"key":"4264_CR21","doi-asserted-by":"crossref","unstructured":"Broseta JJ, Rodr\u00edguez-Espinosa D, Cuadrado E, Rodr\u00edguez N, Bedini JL, Maduell F. Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients. Vaccines (Basel). 27 mars. 2022;10(4):522.","DOI":"10.3390\/vaccines10040522"},{"issue":"2","key":"4264_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1053\/j.ajkd.2021.08.005","volume":"79","author":"I Bensouna","year":"2022","unstructured":"Bensouna I, Caudwell V, Kubab S, Acquaviva S, Pardon A, Vittoz N, et al. SARS-CoV-2 antibody response after a third dose of the BNT162b2 vaccine in patients receiving maintenance Hemodialysis or peritoneal Dialysis. Am J Kidney Dis F\u00e9vr. 2022;79(2):185\u2013e1921.","journal-title":"Am J Kidney Dis F\u00e9vr"},{"key":"4264_CR23","doi-asserted-by":"crossref","unstructured":"Quiroga B, Soler MJ, Ortiz A, Bernat A, D\u00edaz ABM, Mantec\u00f3n CJJ et al. Loss of humoral response 3 months after SARS-CoV-2 vaccination in the CKD spectrum: the multicentric SENCOVAC study. Nephrol Dial Transplant. 11 janv. 2022;gfac007.","DOI":"10.1093\/ndt\/gfac093.001"},{"issue":"2","key":"4264_CR24","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/ndt\/gfab299","volume":"37","author":"T Robert","year":"2022","unstructured":"Robert T, Lano G, Giot M, Fouri\u00e9 T, de Lamballeri X, Jehel O, et al. Humoral response after SARS-CoV-2 vaccination in patients undergoing maintenance haemodialysis: loss of immunity, third dose and non-responders. Nephrol Dial Transpl 25 Janv. 2022;37(2):390\u20132.","journal-title":"Nephrol Dial Transpl 25 Janv"},{"key":"4264_CR25","doi-asserted-by":"publisher","first-page":"781888","DOI":"10.3389\/fmed.2022.781888","volume":"9","author":"T Agur","year":"2022","unstructured":"Agur T, Ben-Dor N, Herman-Edelstein M, Steinmetz T, Lichtenberg S, Schneider S, et al. Longevity of humoral response six months following BNT162b2 vaccine in Dialysis patients. Front Med (Lausanne). 2022;9:781888.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"4264_CR26","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1002\/hsr2.1858","volume":"7","author":"E Goggins","year":"2024","unstructured":"Goggins E, Sharma B, Ma JZ, Gautam J, Bowman B. Humoral immunity trends in a Hemodialysis cohort following SARS-CoV-2 mRNA booster: A cohort study. Health Sci Rep F\u00e9vr. 2024;7(2):e1858.","journal-title":"Health Sci Rep F\u00e9vr"},{"key":"4264_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejca.2021.12.011","volume":"162","author":"J Barri\u00e8re","year":"2022","unstructured":"Barri\u00e8re J, Carles M, Audigier-Valette C, Re D, Adjtoutah Z, Seitz-Polski B, et al. Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: should humoral responses be monitored? A position Article. Eur J Cancer F\u00e9vr. 2022;162:182\u201393.","journal-title":"Eur J Cancer F\u00e9vr"},{"issue":"37","key":"4264_CR28","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 1 Oct. 2023;44(37):3627\u201339.","journal-title":"Eur Heart J 1 Oct"},{"issue":"5","key":"4264_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"key":"4264_CR30","doi-asserted-by":"publisher","first-page":"6186543","DOI":"10.1155\/2016\/6186543","volume":"2016","author":"CM Kelly","year":"2016","unstructured":"Kelly CM, Shahrokni A. Moving beyond Karnofsky and ECOG performance status assessments with new technologies. J Oncol. 2016;2016:6186543.","journal-title":"J Oncol"},{"issue":"7","key":"4264_CR31","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2215\/CJN.03500321","volume":"16","author":"A Grupper","year":"2021","unstructured":"Grupper A, Sharon N, Finn T, Cohen R, Israel M, Agbaria A, et al. Humoral response to the Pfizer BNT162b2 vaccine in patients undergoing maintenance Hemodialysis. CJASN Juill. 2021;16(7):1037\u201342.","journal-title":"CJASN Juill"},{"issue":"11","key":"4264_CR32","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","volume":"27","author":"S Feng","year":"2021","unstructured":"Feng S, Phillips DJ, White T, Sayal H, Aley PK, Bibi S, et al. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med Nov. 2021;27(11):2032\u201340.","journal-title":"Nat Med Nov"},{"key":"4264_CR33","doi-asserted-by":"crossref","unstructured":"Casas Deza D, Juli\u00e1n Gomara AB, Caudevilla Biota E, Beltr\u00e1n B, Dom\u00e8nech E, Guti\u00e9rrez Casbas A, et al. oct. A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study). Gastroenterolog\u00eda y hepatolog\u00eda (English Edition). 2024;47(8):821\u201333.","DOI":"10.1016\/j.gastre.2024.04.041"},{"key":"4264_CR34","doi-asserted-by":"crossref","unstructured":"Morbidity and mortality of renal. dialysis: an NIH consensus conference statement. Consensus Development Conference Panel. Ann Intern Med. 1 juill 1994;121(1):62\u201370.","DOI":"10.7326\/0003-4819-121-1-199407010-00013"},{"issue":"1","key":"4264_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/aor.14376","volume":"47","author":"TD Reid","year":"2023","unstructured":"Reid TD, Kratzke I, Dayal D, Raff L, Serrano P, Kumar A, et al. The role of extracorporeal membrane oxygenation in adult kidney transplant patients: A qualitative systematic review of literature. Artif Organs Janv. 2023;47(1):24\u201337.","journal-title":"Artif Organs Janv"},{"issue":"3","key":"4264_CR36","doi-asserted-by":"publisher","first-page":"308","DOI":"10.7326\/M20-4511","volume":"174","author":"JG Ray","year":"2021","unstructured":"Ray JG, Schull MJ, Vermeulen MJ, Park AL. Association between ABO and Rh blood groups and SARS-CoV-2 infection or severe COVID-19 illness: A Population-Based cohort study. Ann Intern Med Mars. 2021;174(3):308\u201315.","journal-title":"Ann Intern Med Mars"},{"issue":"1","key":"4264_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/21505594.2021.2019959","volume":"13","author":"S Gil-Manso","year":"2022","unstructured":"Gil-Manso S, Miguens Blanco I, Motyka B, Halpin A, L\u00f3pez-Esteban R, P\u00e9rez-Fern\u00e1ndez VA, et al. ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2. Virulence D\u00e9c. 2022;13(1):30\u201345.","journal-title":"Virulence D\u00e9c"},{"key":"4264_CR38","doi-asserted-by":"publisher","first-page":"907615","DOI":"10.3389\/fimmu.2022.907615","volume":"13","author":"T Davidovic","year":"2022","unstructured":"Davidovic T, Schimpf J, Abbassi-Nik A, Stockinger R, Sprenger-M\u00e4hr H, Lhotta K, et al. Humoral and cellular immune response after a 3-Dose heterologous SARS-CoV-2 vaccination using the mRNA-BNT162b2 and viral vector Ad26COVS1 vaccine in Hemodialysis patients. Front Immunol. 2022;13:907615.","journal-title":"Front Immunol"},{"key":"4264_CR39","doi-asserted-by":"crossref","unstructured":"Kitamura M, Takazono T, Yamaguchi K, Tomura H, Yamamoto K, Harada T et al. Favorable Humoral Response to Third Dose of BNT162b2 in Patients Undergoing Hemodialysis. J Clin Med. 8 avr. 2022;11(8):2090.","DOI":"10.3390\/jcm11082090"},{"issue":"11","key":"4264_CR40","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1093\/ckj\/sfab152","volume":"14","author":"M Dekervel","year":"2021","unstructured":"Dekervel M, Henry N, Torreggiani M, Pouteau LM, Imiela JP, Mellaza C, et al. Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis. Clin Kidney J Nov. 2021;14(11):2349\u201355.","journal-title":"Clin Kidney J Nov"},{"issue":"2","key":"4264_CR41","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.kint.2021.10.040","volume":"101","author":"M Espi","year":"2022","unstructured":"Espi M, Charmetant X, Barba T, Mathieu C, Pelletier C, Koppe L, et al. A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance Hemodialysis. Kidney Int F\u00e9vr. 2022;101(2):390\u2013402.","journal-title":"Kidney Int F\u00e9vr"},{"key":"4264_CR42","doi-asserted-by":"crossref","unstructured":"Nacasch N, Cohen-Hagai K, Tayar N, Levian A, Rashid G, Benchetrit S, et al. Humoral response to hepatitis B and COVID-19 vaccine among maintenance Hemodialysis patients. Vaccines. 2022;10(10):1670.","DOI":"10.3390\/vaccines10101670"},{"key":"4264_CR43","doi-asserted-by":"crossref","unstructured":"Tillmann FP, Figiel L, Ricken J, Still H, Korte C, Plassmann G, et al. Evolution of SARS-CoV-2-Neutralizing antibodies after two standard dose vaccinations, risk factors for Non-Response and effect of a third dose booster vaccination in Non-Responders on hemodialysis: a prospective Multi-Centre cohort study. J Clin Med. 2021;10(21):5113.","DOI":"10.3390\/jcm10215113"},{"issue":"4","key":"4264_CR44","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s10157-018-1676-x","volume":"23","author":"H\u0130 Erdo\u011fdu","year":"2019","unstructured":"Erdo\u011fdu H\u0130, Atalay E, G\u00fcrsoy G, Canbakan B, Akt\u00fcrk S, Yaz\u0131c\u0131 C, et al. Factors affecting inadequate response to HBV vaccine in Hemodialysis patients: Northeast Anatolia survey with six Hemodialysis centers. Clin Exp Nephrol Avr. 2019;23(4):530\u20136.","journal-title":"Clin Exp Nephrol Avr"},{"issue":"sept","key":"4264_CR45","first-page":"ASN2021070908","volume":"29","author":"J Van Praet","year":"2021","unstructured":"Van Praet J, Reynders M, De Bacquer D, Viaene L, Schoutteten MK, Caluw\u00e9 R, et al. Predictors and dynamics of the humoral and cellular immune response to SARS-CoV-2 mRNA vaccines in Hemodialysis patients: A multicenter observational study. J Am Soc Nephrol. 2021;29(sept):ASN2021070908.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"4264_CR46","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/ndt\/gfac031","volume":"37","author":"M Kolland","year":"2022","unstructured":"Kolland M, Riedl R, Bachler B, Ribitsch W, Niedrist T, Meissl AM, et al. Decreased response to the mRNA anti-SARS-CoV-2 vaccine in hepatitis B vaccine non-responders and frail patients treated with peritoneal dialysis. Nephrol Dial Transpl 25 Mai. 2022;37(6):1188\u201390.","journal-title":"Nephrol Dial Transpl 25 Mai"},{"issue":"1","key":"4264_CR47","doi-asserted-by":"publisher","first-page":"10842","DOI":"10.1038\/s41467-024-55187-w","volume":"15","author":"D Peroumal","year":"2024","unstructured":"Peroumal D, Jawale CV, Choi W, Rahimi H, Antos D, Li DD, et al. The survival of B cells is compromised in kidney disease. Nat Commun 30 D\u00e9c. 2024;15(1):10842.","journal-title":"Nat Commun 30 D\u00e9c"},{"key":"4264_CR48","doi-asserted-by":"crossref","unstructured":"Kolb T, Fischer S, M\u00fcller L, L\u00fcbke N, Hillebrandt J, Andr\u00e9e M, et al. Impaired immune response to SARS-CoV-2 vaccination in Dialysis patients and in kidney transplant recipients. Kidney360. 2021;2(9):1491\u20138.","DOI":"10.34067\/KID.0003512021"},{"key":"4264_CR49","doi-asserted-by":"crossref","unstructured":"Guinault D, Bernier M, Delarche A, Neuville S, Milioto O, Molinari N, et al. Immunogenicity of the BNT162b2 vaccine in patients undergoing maintenance Hemodialysis is associated with medical conditions. Nephron 27 avr 2022;146(6):553\u20138.","DOI":"10.1159\/000524292"},{"key":"4264_CR50","doi-asserted-by":"crossref","unstructured":"Agur T, Zingerman B, Ben-Dor N, Alkeesh W, Steinmetz T, Rachamimov R et al. Humoral Response to the Third Dose of BNT162b2 COVID-19 Vaccine among Hemodialysis Patients. Nephron. 27 juill. 2022;1\u20138.","DOI":"10.1159\/000525519"},{"key":"4264_CR51","doi-asserted-by":"crossref","unstructured":"Jacobson-Naftali M, Azoulay O, Frishman S, Godny L, Zingerman B, Rozen-Zvi B et al. The Humoral Response to SARS-CoV-2 Vaccine in Hemodialysis Patients Is Correlated with Nutritional Status. Vaccines (Basel). 24 juin. 2023;11(7):1141.","DOI":"10.3390\/vaccines11071141"},{"key":"4264_CR52","doi-asserted-by":"crossref","unstructured":"Van Praet JT, Vandecasteele S, De Roo A, Vynck M, De Vriese AS, Reynders M. Dynamics of the cellular and humoral immune response after BNT162b2 messenger ribonucleic acid coronavirus disease 2019 (COVID-19) vaccination in COVID-19-Naive nursing home residents. J Infect Dis. 2021;224(10):1690\u20133.","DOI":"10.1093\/infdis\/jiab458"},{"issue":"11","key":"4264_CR53","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.3390\/jcm11113187","volume":"11","author":"FP Tillmann","year":"2022","unstructured":"Tillmann FP, Figiel L, Ricken J, Still H, Korte C, Pla\u00dfmann G, et al. Effect of third and fourth mRNA-Based booster vaccinations on SARS-CoV-2 neutralizing antibody titer formation, risk factors for Non-Response, and outcome after SARS-CoV-2 Omicron breakthrough infections in patients on chronic hemodialysis: A prospective multicenter cohort study. J Clin Med 2 Juin. 2022;11(11):3187.","journal-title":"J Clin Med 2 Juin"},{"key":"4264_CR54","doi-asserted-by":"crossref","unstructured":"Simon B, Rubey H, Gromann M, Knopf-V\u00f6lkerer A, Hemedi B, Zehetmayer S et al. SARS-CoV-2 Antibody and T Cell Response after a Third Vaccine Dose in Hemodialysis Patients Compared with Healthy Controls. Vaccines (Basel). 28 avr. 2022;10(5):694.","DOI":"10.3390\/vaccines10050694"},{"key":"4264_CR55","doi-asserted-by":"crossref","unstructured":"Aoun M, Kahwaji RM, Sleilaty G, Boueri C, Hawi J, Khalil CB et al. Factors predictive of anti-spike antibody titers after COVID-19 vaccination in hemodialysis patients. Adv Clin Exp Med. 19 avr. 2022.","DOI":"10.17219\/acem\/147360"},{"issue":"10","key":"4264_CR56","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s11255-017-1616-9","volume":"49","author":"A Asan","year":"2017","unstructured":"Asan A, Demirhan H, Sorkun H\u00c7, \u00d6zkan S, Ayd\u0131n M, Ak\u0131n D, et al. Factors affecting responsiveness to hepatitis B immunization in dialysis patients. Int Urol Nephrol Oct. 2017;49(10):1845\u201350.","journal-title":"Int Urol Nephrol Oct"},{"key":"4264_CR57","doi-asserted-by":"crossref","unstructured":"Castellano G, Netti GS, Cantaluppi V, Losappio V, Spadaccino F, Ranieri E et al. PMMA dialyzers modulate both humoral and cell-mediate immune response to anti-COVID-19 vaccine (BNT162b2) in a cohort of chronic hemodialyzed patients. Sci Rep. 28 mai. 2024;14(1):12217.","DOI":"10.1038\/s41598-024-62044-9"},{"key":"4264_CR58","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2147\/IJNRD.S452964","volume":"17","author":"K Hirai","year":"2024","unstructured":"Hirai K, Shimotashiro M, Okumura T, Ookawara S, Morishita Y. Anti-SARS-CoV-2 Spike antibody response to the fourth dose of BNT162b2 mRNA COVID-19 vaccine and associated factors in Japanese Hemodialysis patients. Int J Nephrol Renovasc Dis. 2024;17:135\u201349.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"4","key":"4264_CR59","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s11255-023-03471-x","volume":"55","author":"S Taheri","year":"2023","unstructured":"Taheri S. Efficacy and safety of booster vaccination against SARS-CoV-2 in dialysis and renal transplant patients: systematic review and meta-analysis. Int Urol Nephrol Avr. 2023;55(4):791\u2013802.","journal-title":"Int Urol Nephrol Avr"},{"key":"4264_CR60","doi-asserted-by":"publisher","first-page":"1004045","DOI":"10.3389\/fimmu.2022.1004045","volume":"13","author":"M Becker","year":"2022","unstructured":"Becker M, Cossmann A, L\u00fcrken K, Junker D, Gruber J, Juengling J, et al. Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients. Front Immunol 6 Oct. 2022;13:1004045.","journal-title":"Front Immunol 6 Oct"},{"key":"4264_CR61","doi-asserted-by":"crossref","unstructured":"Hu FH, Jia YJ, Zhao DY, Fu XL, Zhang WQ, Tang W, et al. Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019-positive patients. Clin Microbiol Infect. 18 mars 2023;29(7):835\u201344.","DOI":"10.1016\/j.cmi.2023.03.017"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04264-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04264-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04264-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T13:02:39Z","timestamp":1750683759000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04264-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4264"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04264-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the institutional review board at Amiens University Medical Center (Amiens, France; reference: PI2022_843_0072) on June 5th, 2022). Informed consent was obtained from all patients involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}